A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Nostalgic ’90s movie lovers will find it hard to forget classics like Mrs. Doubtfire, and even harder to forget Harvey ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the ...